IPP Bureau
Zydus receives final USFDA approval for Cyclophosphamide Capsules USP, 25 mg and 50 mg
By IPP Bureau - December 17, 2023
Cyclophosphamide is a chemotherapy medication that slows the growth of cancer cell
Fischer Chemic to acquire Time Medical Internaitonal Ventures India
By IPP Bureau - December 17, 2023
Fischer Chemic will make an entry into the growing market of diagnostic imaging industry with innovative and disruptive technologies
Biocon Biologics recognized as an Asia IP Elite for 2023
By IPP Bureau - December 17, 2023
Biocon Biologics is one among the three pharmaceutical companies from India to be featured on this year's list
Lupin receives USFDA approval for Allopurinol Tablets
By IPP Bureau - December 17, 2023
The product will be manufactured at Lupin's Pithampur facility in India
Panacea Biotec launches EasyFourPol in India
By IPP Bureau - December 17, 2023
Receives registration of Valganciclovir powder for oral solution in Germany
Dr. Reddy's becomes first Indian pharma company to debut on the DJSI
By IPP Bureau - December 17, 2023
Dr. Reddy's has been awarded 'Gold Medal' status by EcoVadis
Cipla to further invest Rs. 42 crore in GoApptiv
By IPP Bureau - December 17, 2023
Expands patient reach to remotest towns by furthering investment in GoApptiv
Lupin Diagnostics opens new laboratory in Chennai
By IPP Bureau - December 17, 2023
The Regional Reference Laboratory in Chennai is equipped with cutting-edge diagnostic technologies
Ami Organics inaugurates new API manufacturing facility
By IPP Bureau - December 17, 2023
This development is a strategic part of the company's commitment to bolstering its position in the advanced pharmaceutical intermediates segment
TÜV SÜD inaugurates € 15 million Laboratory & Training Centre Bengaluru Campus
By IPP Bureau - December 17, 2023
Expansion of presence in India with electrical safety, electromagnetic compatibility and medical device biocompatibility, toxicity and microbiology testing and certification services
Venus Remedies expands global presence with marketing authorisation for enoxaparin from Azerbaijan
By IPP Bureau - December 14, 2023
The company makes its maiden entry into Azerbaijan’s pharmaceutical market
Granules India received ANDA approval for Pantoprazole Sodium Delayed-Release Tablets
By IPP Bureau - December 14, 2023
Pantoprazole Sodium Delayed-Release Tablets are indicated for short-term treatment of Erosive Esophagitis associated with GERD
WHO issues warning on the surge of new age gateway devices among children
By IPP Bureau - December 14, 2023
Mothers Against Vaping also highlights a recent study of young people at risk of experiencing significant respiratory symptoms after just 30 days of electronic cigarette and other new age gateway products use
Pfizer expects 2024 revenue between US$ 58.5 to US$ 61.5 billion
By IPP Bureau - December 14, 2023
Anticipates approx. US$8 billion in revenues for Comirnaty and Paxlovid
Moderna Chief Commercial Officer steps down, President to look over pipeline strategy
By IPP Bureau - December 14, 2023
Announces changes to commercial organization to prepare for multiple product launches in 2024 and 2025
